Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community Practice.

Overview
Identity
Additional Document Info
View All

authors

Michael Nanna, MD, MHS
Kolkailah, Ahmed A
Page, Courtney
Peterson, Eric D
Navar, Ann Marie

publication date

January 1, 2022

published in

JAMA cardiology Journal

has subject area